Zobrazeno 1 - 7
of 7
pro vyhledávání: '"N. Rodrigues Mantuano"'
Autor:
D. König, B. Kasenda, M. Sandholzer, A. Chirindel, A. Zingg, R. Ritschard, H. Thut, K. Glatz, E.A. Kappos, D. Schaefer, C. Kettelhack, J. Passweg, K. Baur, A. Holbro, A. Buser, D. Lardinois, L.T. Jeker, N. Khanna, F. Stenner, M.S. Matter, N. Rodrigues Mantuano, M. Binder, A. Zippelius, H. Läubli
Publikováno v:
Immuno-Oncology and Technology, Vol 24, Iss , Pp 100728- (2024)
Background: Adoptive cell therapy (ACT) with tumor-infiltrating lymphocytes (TIL) is a personalized immunotherapy. The efficacy of TIL-ACT has been demonstrated prospectively in patients with advanced melanoma but is not limited to melanoma patients.
Externí odkaz:
https://doaj.org/article/a77a15df7af5480ea93dda0ce4aa25e6
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
König D; Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland., Sandholzer MT; Department of Biomedicine, University of Basel, Basel, Switzerland., Uzun S; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland., Zingg A; Department of Biomedicine, University of Basel, Basel, Switzerland., Ritschard R; Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland., Thut H; Department of Biomedicine, University of Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland., Glatz K; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland., Kappos EA; Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Schaefer DJ; Department of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland., Kettelhack C; Visceral Surgery, Clarunis University Center for Gastrointestinal and Liver Disease, University Hospital and Claraspital Basel, Basel, Switzerland., Passweg JR; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Hematology, University Hospital Basel, Basel, Switzerland., Holbro A; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Hematology, University Hospital Basel, Basel, Switzerland.; Blood Donation Center Basel, Basel, Switzerland., Baur K; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Hematology, University Hospital Basel, Basel, Switzerland., Medinger M; Division of Hematology, University Hospital Basel, Basel, Switzerland., Buser A; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Hematology, University Hospital Basel, Basel, Switzerland.; Blood Donation Center Basel, Basel, Switzerland., Lardinois D; Department of Thoracic Surgery, University Hospital Basel, Basel, Switzerland., Jeker LT; Department of Biomedicine, University of Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Transplantation Immunology and Nephrology, University Hospital Basel, Basel, Switzerland., Khanna N; Department of Biomedicine, University of Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Stenner F; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland., Kasenda B; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland., Homicsko K; AGORA Cancer Research Center, Lausanne, Switzerland.; Ludwig Institute for Cancer Research, Lausanne, Switzerland.; Department of Oncology, CHUV, Lausanne, Switzerland., Matter M; Institute of Pathology and Medical Genetics, University Hospital Basel, Basel, Switzerland., Rodrigues Mantuano N; Department of Biomedicine, University of Basel, Basel, Switzerland., Zippelius A; Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland., Läubli H; Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Medical Oncology, University Hospital Basel, Basel, Switzerland.; Innovation Focus Cell Therapies, University Hospital Basel, Basel, Switzerland.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2024 Jul 02; Vol. 12 (7), pp. 814-821.
Autor:
Schmassmann P; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Roux J; Bioinformatics Core Facility, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Swiss Institute of Bioinformatics, 4031 Basel, Switzerland., Buck A; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Tatari N; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Hogan S; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Wang J; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Rodrigues Mantuano N; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Wieboldt R; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Lee S; Institute of Molecular Systems Biology, ETH Zurich, 8049 Zurich, Switzerland., Snijder B; Institute of Molecular Systems Biology, ETH Zurich, 8049 Zurich, Switzerland., Kaymak D; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Martins TA; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Ritz MF; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Shekarian T; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., McDaid M; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Weller M; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Weiss T; Department of Neurology, Clinical Neuroscience Center, University Hospital and University of Zurich, 8091 Zurich, Switzerland., Läubli H; Cancer Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital of Basel, 4031 Basel, Switzerland., Hutter G; Brain Tumor Immunotherapy Lab, Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Department of Neurosurgery, University Hospital of Basel, 4031 Basel, Switzerland.
Publikováno v:
Science translational medicine [Sci Transl Med] 2023 Jul 19; Vol. 15 (705), pp. eadf5302. Date of Electronic Publication: 2023 Jul 19.
Autor:
Stanczak MA; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Rodrigues Mantuano N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Kirchhammer N; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Sanin DE; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Jacob F; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Coelho R; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Everest-Dass AV; Institute for Glycomics, Griffith University, Gold Coast Campus, Gold Coast QLD4222, Australia., Wang J; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Trefny MP; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Monaco G; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Bärenwaldt A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Gray MA; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Petrone A; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Kashyap AS; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland., Glatz K; Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland., Kasenda B; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Normington K; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Broderick J; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Peng L; Palleon Pharmaceuticals, Waltham, MA 02451, USA., Pearce OMT; Centre for Tumour Microenvironment, Barts Cancer Institute, Queen Mary University, London EC1M 6BQ, UK., Pearce EL; Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, MD 21287, USA.; Max Planck Institute of Immunobiology and Epigenetics, 79108 Freiburg, Germany., Bertozzi CR; Department of Chemistry, Stanford ChEM-H, and Howard Hughes Medical Institute, Stanford University, Stanford, CA 94305, USA., Zippelius A; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland., Läubli H; Department of Biomedicine, University Hospital and University of Basel, 4031 Basel, Switzerland.; Division of Oncology, Department of Theragnostics, University Hospital Basel, 4031 Basel, Switzerland.
Publikováno v:
Science translational medicine [Sci Transl Med] 2022 Nov 02; Vol. 14 (669), pp. eabj1270. Date of Electronic Publication: 2022 Nov 02.
Autor:
Rodrigues Mantuano N; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Stanczak MA; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland., Oliveira IA; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Kirchhammer N; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland., Filardy AA; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Monaco G; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland., Santos RC; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Fonseca AC; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil., Fontes M; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil., Bastos CS Jr; Hospital Naval Marcílio Dias, Rio de Janeiro, Brazil., Dias WB; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil., Zippelius A; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland.; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland., Todeschini AR; Instituto de Biofisica Carlos Chagas Filho, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil. heinz.laeubli@unibas.ch adrianet@biof.ufrj.br., Läubli H; Cancer Immunology Laboratory, Department of Biomedicine, University of Basel, Basel, Switzerland. heinz.laeubli@unibas.ch adrianet@biof.ufrj.br.; Division of Oncology, Department of Internal Medicine, University Hospital Basel, Basel, Switzerland.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2020 Oct; Vol. 8 (10), pp. 1262-1272. Date of Electronic Publication: 2020 Jul 27.
Autor:
Rodrigues Mantuano N; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland., Natoli M; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland., Zippelius A; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland., Läubli H; Department of Biomedicine, Universitätsspital Basel, Basel, Switzerland heinz.laeubli@unibas.ch.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2020 Oct; Vol. 8 (2).